{"id":1216881,"date":[{"year":1999,"month":9,"day":9}],"page":"8","source":"本报","region":"","masthead":"文汇财经·投资新闻","special_issue":"文汇财经","column":"财经快讯","genre":"","count":"356","ytitle":"","mtitle":"上半年制药业利润增长快","ftitle":"","authors":["赵安绩"],"text":[{"type":"paragraph","text":"本报讯(记者赵安绩)　近期已披露完毕的今年上市公司中报显示，制药行业不但主营收入同比增幅较大，而且其净利润同比增幅居各行业之首，此两项指标最差的是商业。"},{"type":"paragraph","text":"从主营收入同比增幅看，电力行业是33.08%，居首位，其次是制药行业，增幅是2266%。但电力行业的净利润同比增幅仅21.59%，而制药行业却高达45.78%。在这一行业中，净利润同比增幅较高的是双鹤药业、东北药、桐君阁、青海明胶，其增幅分别为185%、150%、128%、90%。青海三普、哈医药、古汉集团、吉林敖东等净利润增幅也较大。"},{"type":"paragraph","text":"商业是制药、电力、化工、家电、钢铁、建材、汽车、房地产等9个行业中净利润增幅最差的。宁波华联、成百集团、王府井其增幅皆为负数，分别为-3922%、-260%、-118%。"}]}